Detalhe da pesquisa
1.
Atezolizumab for Advanced Alveolar Soft Part Sarcoma.
N Engl J Med
; 389(10): 911-921, 2023 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37672694
2.
Diagnostic performance of [68Ga]DOTATATE PET/CT, [18F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma.
Eur Radiol
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38625612
3.
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620).
Breast Cancer Res Treat
; 198(3): 487-498, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36853577
4.
Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using 68Ga-DOTATATE, FDG, 18F-FDOPA, and 18F-FDA).
AJR Am J Roentgenol
; 218(2): 342-350, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34431366
5.
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute.
Oncologist
; 26(10): e1883-e1886, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34397143
6.
Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors.
Invest New Drugs
; 39(6): 1577-1586, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34180036
7.
A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction.
Br J Clin Pharmacol
; 85(11): 2499-2511, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31271459
8.
Cediranib phase-II study in children with metastatic alveolar soft-part sarcoma (ASPS).
Pediatr Blood Cancer
; 66(12): e27987, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31502400
9.
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma.
Cancer
; 124(7): 1374-1382, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29338080
10.
A Phase I Study of Ganetespib and Ziv-Aflibercept in Patients with Advanced Carcinomas and Sarcomas.
Oncologist
; 23(11): 1269-e125, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29853657
11.
First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile.
Invest New Drugs
; 36(2): 230-239, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28808818
12.
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer.
Invest New Drugs
; 34(3): 355-63, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26996385
13.
Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors.
Invest New Drugs
; 33(4): 921-30, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26082332
14.
Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors.
Cancer Chemother Pharmacol
; 93(3): 177-189, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010394
15.
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J.
Clin Cancer Res
; 30(7): 1273-1280, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433347
16.
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E.
JCO Precis Oncol
; 8: e2300454, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38591867
17.
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2.
JCO Precis Oncol
; 8: e2300407, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603650
18.
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1.
JCO Precis Oncol
; 8: e2300406, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603651
19.
Rethinking Oncologic Treatment Strategies with Interleukin-2.
Cells
; 12(9)2023 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37174716
20.
NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors.
Cancer Res Commun
; 3(6): 1113-1117, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377610